Estramustine is an estrogen-derived cytostatic antineoplastic agent classified as a bis(2-chloroethyl)carbamate derivative of estradiol that is primarily used in the clinical treatment of prostate cancer.… Read more
Estramustine is an estrogen-derived cytostatic antineoplastic agent classified as a bis(2-chloroethyl)carbamate derivative of estradiol that is primarily used in the clinical treatment of prostate cancer. By acting as both a prostatic hormone antagonist and an alkylating agent, it inhibits tumor cell division and progression. To support critical analytical workflows, this category includes high-quality reference standards for Estramustine API, as well as a selection of related impurities and stable isotope labelled compounds. Pharmaceutical laboratories rely on these reference materials for essential applications such as impurity profiling, method development, and rigorous quality control validation. Utilizing these compounds ensures accurate quantification and identification throughout the drug development process, allowing for precise monitoring of degradation products and metabolic pathways during stability testing.